India

Pharmaceutical 

The Indian pharmaceutical industry is estimated to be worth USD 21.5 billion as of 2009-10 and is expected to grow at a CAGR of 16-18 percent during 2009-2010 to 2014-15 to reach USD 43-46 billion.

 

Pharmaceutical

 

There is a huge opportunity for Indian generics players with many blockbuster drugs going off-patent in the next five years. The sub-sectors such as biopharmaceuticals and Contract Research and Manufacturing Services (CRAMS) are expected to become the new frontiers of growth.  India is increasingly being looked at as a preferred destination for clinical trials and other services.

 

With such high growth predicted for the industry, the challenges the industry will have to overcome will be at a global level.

How can we help

 

KPMG’s industry-focused professionals understand the pharmaceutical sector and can assist you in recognizing and capitalizing on the opportunities that exist. Our professionals offer a powerful blend of industry insight and proven credentials to help you and your organization successfully achieve its mission and objectives. Our audit, tax and advisory practices offer a bouquet of solutions to the pharmaceutical industry. A few of these solutions are listed below:

  

    Tax Advisory and Compliance Services

    • Corporate Tax and Regulatory Services
    • Transfer Pricing Services
    • Indirect Tax Services including Tax Outsourcing
    • International Executive Services
    • M&A Tax Services
    • Others

     

    Advisory

    • M&A Advisory
    • Financing Advisory
    • Valuation Services
    • Due Diligence Services
    • Risk Management Services
    • Internal Audit Services
    • Fraud & Misconduct Services
    • Forensic Technology Services
    • Business Plan Formulation and Implementation
    • Market Entry and Expansion Strategy
    • Others